However, in this model, which mimics an especially pharmacoresistant form of FNE, epilepsia partialis continua (EPC; Cockerell et al., 1996), discrete seizures lasting >5 s are rare (see also Kätzel et al., 2014), so the effectiveness of potassium channel gene therapy in more common forms of epilepsy remains to be demonstrated. Here, KCNA3 is linked to epilepsy.